Streetbeat News

Revenues

SCLX

Scilex Holding Company (NASDAQ:SCLX) announced record monthly revenue in October 2023 for its non-opioid pain management product, ZTlido. The company reported gross sales for October 2023 in the range of $14.5 million to $15.5 million, and year-to-date gross sales through October 2023 in the range of $110.0 million to $120.0 million, representing a growth of 47% to 60% compared to the same period in 2022. Net sales for October 2023 were in the range of $4.0 million to $5.0 million, with year-to-date net sales through October 2023 in the range of $35.0 million to $40.0 million, representing a growth of 15% to 32% compared to the same period in 2022.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:23 pm

CFG

DAL

LXFR

TEX

Insiders at Delta Air Lines, Luxfer Holdings, Citizens Financial Group, and Terex Corporation have recently purchased shares in their respective companies. This could indicate confidence in the companies' prospects or that the insiders view the stocks as a bargain. Luxfer Holdings and Terex Corporation posted upbeat sales for the third quarter, while Citizens Financial Group reported a revenue decline of 7% Y/Y. Delta Air Lines reported better-than-expected earnings for its third quarter.

Portfolio Pulse from Lisa Levin

November 01, 2023 | 1:08 pm

NHTC

Natural Health Trends Corp. reported Q3 2023 earnings per share (EPS) of $0.02, up from $0 year over year (YoY). However, revenue fell to $10.6M from $11.7M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:02 pm

DD

DuPont De Nemours reported mixed Q3 financial results and lowered its FY23 revenue guidance below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:49 pm

YUM

Yum Brands has expanded its nuggets to Latin America and Caribbean markets in Q3 following a successful U.S. launch. The company reported an 'incredible consumer reception' that helped drive significant sales.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:45 pm

USPH

U.S. Physical Therapy, Inc. (USPH) has announced the acquisition of an industrial injury prevention services and ergonomics software business by its subsidiary, Briotix Health Limited Partnership. The total purchase price was approximately $4.0 million. The combined businesses currently generate about $2.6 million in annual revenues. The acquisition is expected to increase USPH's IIP services business and add a new solution to Briotix's offerings.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:37 pm

FWRG

First Watch Restaurant Group (FWRG) projects FY23 same-restaurant sales growth of 7%-8%, revenue growth of 20%-21%, and adjusted EBITDA of $91M-$92M.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:32 pm

LEXX

Lexaria Bioscience Corp. (NASDAQ:LEXX) is expanding its studies of its proprietary DehydraTECH platform in the GLP-1 drug space, a market estimated to reach $82.93 billion by 2027. The company's early studies in 2022 showed positive effects of lowering glucose levels, body weight, and triglyceride levels, and increased locomotor activity.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:31 pm

FRSX

Foresight Autonomous Holdings Ltd. (FRSX) is focusing on defense, industrial vehicles, and Eye-Net Mobile initiatives in the short term. The company has signed several agreements and achieved milestones in these sectors, including a $4 million deal with Elbit Systems and a $51 million deal with SUNWAY-AI Technology. Foresight is also pursuing projects in the automotive industry, with partnerships with Hitachi Astemo and ZF Friedrichschafen. The company's Eye-Net subsidiary has partnered with SoftBank and received an order from a leading Japanese vehicle manufacturer.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:28 pm

SRAD

Sportradar Group has projected its FY23 revenue to be between €870M-€880M, representing a YoY increase of 19%-21%.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:24 pm